August 25, 2025

Soleno Therapeutics, Inc. (SLNO): Investor Outlook on Potential 72.96% Upside in Biotech

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a burgeoning name in the biopharmaceutical sector, is attracting considerable attention from investors, especially given its compelling upside potential of 72.96%. With a focus on..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Glimpse into Its Growth Potential Amidst Strong Buy Ratings

iRhythm Technologies, Inc. (NASDAQ: IRTC) is capturing attention within the healthcare sector, particularly in the medical device industry. Based in San Francisco, this digital healthcare company specializes in innovative ambulatory..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring an 85% Upside Potential and Robust Pipeline

For investors seeking exposure to the biopharmaceutical sector, Cytokinetics, Incorporated (NASDAQ: CYTK) presents an intriguing opportunity with its focus on developing groundbreaking muscle activators and inhibitors. As a late-stage biopharmaceutical..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Uncharted Waters with a $6.33 Billion Market Cap

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based leader in the field of Traditional Chinese Medicine (TCM), has captured investor attention with its ambitious focus on neurocognitive disorders, including..

Grifols, S.A. (GRFS) Stock Analysis: Exploring the 20% Upside Potential for Investors

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, stands out as a key figure in the plasma therapeutic industry. Based in Barcelona, Spain, this company has been..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 1,353.80% Revenue Growth Surge

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is making waves in the biotechnology sector, showcasing an impressive trajectory that has piqued the interest of individual investors. The company, headquartered in West Conshohocken,..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Pioneer with a 30.9% Revenue Growth Surge

Guardant Health, Inc. (NASDAQ: GH), a prominent player in the healthcare sector, is making significant strides in the diagnostics and research industry. Headquartered in Palo Alto, California, this precision oncology..

ADMA Biologics Inc (ADMA): Investor Outlook Highlights a Potential 63% Upside

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company specializing in plasma-derived biologics, is capturing investor attention with its promising market position and potential upside. With a market capitalization of $4.25..

Bio-Rad Laboratories, Inc. (BIO): Investor Outlook with a 7.46% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $7.99 billion, this U.S.-based company continues to..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Evaluating a Promising 15.76% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing investor attention with its robust growth metrics and promising upside potential, as reflected in recent analyst ratings. Operating in the dynamic healthcare..

Verona Pharma plc (VRNA) Stock Analysis: Navigating the Biotech Wave with a Strong Market Cap

Verona Pharma plc (NASDAQ: VRNA) has emerged as a notable player in the biotechnology sector, capturing investor attention with its substantial market capitalization of $8.97 billion. Headquartered in London, this..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Discovering a 24.12% Potential Upside in a Resilient Healthcare Player

Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent name in the over-the-counter (OTC) health and personal care products sector, is making waves with its diverse product portfolio and significant market..

Bruker Corporation (BRKR): Analyst Ratings and 31.48% Potential Upside Capture Investor Attention

Bruker Corporation (NASDAQ: BRKR), a stalwart in the healthcare sector specializing in medical devices, is making waves with its scientific instruments and diagnostic solutions. Based in Billerica, Massachusetts, Bruker has..

Teleflex Incorporated (TFX): Investor Outlook with Attractive 8.26% Potential Upside

Teleflex Incorporated (NYSE: TFX), a major player in the healthcare sector, specializes in the design, development, and manufacture of single-use medical devices. With a market capitalization of $5.72 billion, Teleflex..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A 50% Upside Potential in the Healthcare Sector

Investors in Inspire Medical Systems, Inc. (INSP) have reasons to remain optimistic about the company’s future, as analysts project a significant upside potential of 50.16%. With a current stock price..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Challenges with a 29% Revenue Growth

Oscar Health, Inc. (OSCR), a prominent player in the healthcare technology sector, is navigating a complex financial landscape. As a company that provides innovative health plans and platforms like +Oscar..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a Potential 51% Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a noteworthy contender in the healthcare sector, particularly in the realm of specialty and generic drug manufacturing. Headquartered in Bedford, Massachusetts, the company..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating the Healthcare Giant’s Market Position

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, operates within the medical devices industry. Headquartered in Watford, United Kingdom, the company boasts a robust..

West Pharmaceutical Services (WST) Stock Analysis: Uncovering a 27.64% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) is emerging as a compelling investment opportunity within the robust healthcare sector. With a market capitalization of $17.82 billion, this U.S.-based company specializes in..

Globus Medical, Inc. (GMED) Stock Analysis: Strong Growth Potential with 32% Upside

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specializes in developing and commercializing medical devices for musculoskeletal disorders. With a market capitalization of $8.44 billion, Globus..

Search

Funds

August 25, 2025

Search

Funds

August 25, 2025

FTSE 100

Funds